Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …
vaccination was implemented. We did a systematic review and meta-analysis of the …
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based …
M Falcaro, A Castañon, B Ndlela, M Checchi, K Soldan… - The Lancet, 2021 - thelancet.com
Background Human papillomavirus (HPV) immunisation with a bivalent vaccine (Cervarix)
was introduced in England, UK, in Sept 1, 2008: routine vaccination was offered to girls …
was introduced in England, UK, in Sept 1, 2008: routine vaccination was offered to girls …
HPV vaccination and cancer prevention
A Athanasiou, S Bowden, M Paraskevaidi… - Best Practice & …, 2020 - Elsevier
Prophylactic vaccines have been found to be highly effective in preventing infection and pre-
invasive and invasive cervical, vulvovaginal and anal disease caused by the vaccine types …
invasive and invasive cervical, vulvovaginal and anal disease caused by the vaccine types …
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
This paper summarises the position of ESGO and EFC on cervical screening based on
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
DR Brown, EA Joura, GP Yen, S Kothari… - Vaccine, 2021 - Elsevier
Background The extent of cross-protection provided by currently licensed bivalent and
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening …
M Rebolj, F Pesola, C Mathews, D Mesher… - British journal of …, 2022 - nature.com
Abstract Background In England, bivalent vaccination (Cervarix) against high-risk human
papillomavirus (HR-HPV) genotypes 16/18 was offered in a population-based catch-up …
papillomavirus (HR-HPV) genotypes 16/18 was offered in a population-based catch-up …
[HTML][HTML] Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for …
EA Joura, M Kyrgiou, FX Bosch, V Kesic… - European Journal of …, 2019 - Elsevier
Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They
have been highly effective in preventing infection and disease caused by the vaccine types …
have been highly effective in preventing infection and disease caused by the vaccine types …
It is time for universal HPV vaccination
G Prue, P Baker, D Graham, C Nutting, P Greenhouse… - The Lancet, 2018 - thelancet.com
Potential adverse consequences of physical overexertion have been periodic ally debated
since the legend of Pheidippides, who was said to have collapsed and died after running 26 …
since the legend of Pheidippides, who was said to have collapsed and died after running 26 …
Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: evidence of direct and herd effects of vaccination
LE Markowitz, AL Naleway, RM Lewis, B Crane… - Vaccine, 2019 - Elsevier
Background Human papillomavirus (HPV) vaccine has been recommended in the United
States since 2006 for routine vaccination of girls at age 11–12 years and through age 26 …
States since 2006 for routine vaccination of girls at age 11–12 years and through age 26 …